News
Thursday, December 19th, 2019
Sirona Biochem CEO Letter to Shareholders
Monday, December 2nd, 2019
Sirona Biochem Reports 100% Safety in First Tox Study for Increased Concentration of TFC-1067
Wednesday, October 30th, 2019
Sirona Biochem Proceeds to First Clinical Tests for Higher Concentrations to Increase Commercial Value of Skin Lightening Compound TFC-1067
Wednesday, October 23rd, 2019
Sirona Biochem Hires Shanghai-based Chemistry Engineer to Select Local Manufacturer for Skin-Lightening Compound TFC-1067
Sunday, October 20th, 2019
Sirona Biochem: Agreement Signing Ceremony with Rodan + Fields at Cosmetic 360 Conference in Paris
Wednesday, October 9th, 2019
Sirona Biochem Signs Binding Term Sheet with Cosmetic Distributor in China
Wednesday, September 25th, 2019
Sirona Biochem to Present Additional Clinical Results of TFC-1067 at Cosmetic 360 in Paris, France
Wednesday, September 18th, 2019
Sirona Biochem Signs Definitive License & Supply Agreement with Skincare Industry Leader Rodan + Fields
Wednesday, September 11th, 2019
Sirona Biochem Adopts Shareholder Rights Plan
Wednesday, July 10th, 2019
Sirona Biochem Announces Successful Close of Oversubscribed Private Placement
Product Development
While carbohydrate-based molecules offer immense commercial potential, we are focusing on three programs at this time.
Social Links Sidebar